{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T06:39:51Z","timestamp":1775025591326,"version":"3.50.1"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Gastric cancer (GC) is the fifth most commonly diagnosed malignancy and the fourth leading cause of cancer-related mortality worldwide. RNA-binding motif protein 3 (RBM3) has been associated as a prognostic marker in several cancers; however, its genetic contribution and functional role in gastric cancer remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Genome-wide association study (GWAS) data was integrated with experimental validation to investigate the role of RBM3 in GC. RBM3-associated expression quantitative trait loci (eQTLs) were identified from a GWAS of 3,301 individuals and evaluated for their association with GC risk using a large-scale GWAS comprising 456,348 individuals. Colocalization analysis was performed using stomach tissue eQTL data. RBM3 expression was assessed in 60 paired GC and adjacent normal tissues and in multiple GC cell lines. Functional effects of RBM3 modulation were examined through proliferation, colony formation, migration, invasion, and xenograft assays.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Several independent variants within the RBM3 locus showed a consistent protective association with GC risk and were linked to RBM3 expression regulation. RBM3 expression was significantly reduced in GC tissues compared with adjacent normal tissues (P &amp;lt; 0.001). Low RBM3 expression correlated with advanced tumor stage (III\u2013IV), lymph node and distant metastasis, and larger tumor size. Functionally, RBM3 overexpression inhibited GC cell proliferation, clonogenicity, migration, and invasion\n                      <jats:italic>in vitro<\/jats:italic>\n                      .\n                      <jats:italic>In vivo<\/jats:italic>\n                      , RBM3 overexpression suppressed xenograft tumor growth, reduced Ki67-positive proliferation, and enhanced apoptotic activity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings demonstrate that RBM3 acts as a genetically supported tumor suppressor in gastric cancer. RBM3-associated germline variants contribute to GC susceptibility, and RBM3 downregulation promotes aggressive tumor behavior. RBM3 therefore represents a promising biomarker and potential therapeutic target in gastric cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1790197","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T04:42:35Z","timestamp":1775018555000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["RBM3-associated germline variants and their functional role in gastric cancer susceptibility and progression"],"prefix":"10.3389","volume":"16","author":[{"given":"Qingsheng","family":"Zheng","sequence":"first","affiliation":[{"name":"Department of General surgery, The Affiliated People\u2019s Hospital of Fujian University of Traditional Chinese Medicine","place":["Fuzhou, Fujian, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of General surgery, The Affiliated People\u2019s Hospital of Fujian University of Traditional Chinese Medicine","place":["Fuzhou, Fujian, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueying","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of General surgery, The Affiliated People\u2019s Hospital of Fujian University of Traditional Chinese Medicine","place":["Fuzhou, Fujian, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101404","article-title":"The current and future incidence and mortality of gastric cancer in 185 countries, 2020\u201340: A population-based modelling study","volume":"47","author":"Morgan","year":"2022","journal-title":"EClinicalMedicine"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101834","article-title":"Development of a tongue image-based machine learning tool for the diagnosis of gastric cancer: a prospective multicentre clinical cohort study","volume":"57","author":"Yuan","year":"2023","journal-title":"EClinicalMedicine"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2022.0655","article-title":"Early detection of gastric cancer in China: progress and opportunities","volume":"19","author":"Xu","year":"2022","journal-title":"Cancer Biol Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-22-537","article-title":"Diagnostic value of combined detection of CA72-4, CA19-9, and carcinoembryonic antigen comparing to CA72\u20134 alone in gastric cancer: a systematic review and meta-analysis","volume":"11","author":"Wang","year":"2022","journal-title":"Transl Cancer Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.892468","article-title":"Risk factors for gastric cancer: A comprehensive analysis of observational studies","volume":"10","author":"Hui","year":"2023","journal-title":"Front Public Health"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/hygiene3030019","article-title":"Gastric cancer epidemiology: Current trend and future direction","volume":"3","author":"Iwu","year":"2023","journal-title":"Hygiene"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/imr.13253","article-title":"Germline mechanisms of immunotherapy toxicities in the era of genome\u2010wide association studies","volume":"318","author":"Gusev","year":"2023","journal-title":"Immunol Rev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.928783","article-title":"Systematic review of gastric cancer-associated genetic variants, gene-based meta-analysis, and gene-level functional analysis to identify candidate genes for drug development","volume":"13","author":"Lee","year":"2022","journal-title":"Front Genet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41392-022-01190-w","article-title":"Signaling pathways and therapeutic interventions in gastric cancer","volume":"7","author":"Lei","year":"2022","journal-title":"Signal Transduct Tgt Ther"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3233\/CBM-230489","article-title":"Identification of RNA-binding protein RBMS3 as a potential biomarker for immunotherapy in bladder cancer","volume":"41","author":"Praygod","year":"2024","journal-title":"Cancer Biomarkers"},{"key":"B11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.11648\/j.ijacm.20251302.13","article-title":"Research advances in the biological functions of RBM3","volume":"13","author":"Feiyu","year":"2025","journal-title":"Int J Anesth Clin Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1555115","article-title":"Therapeutic modulation of protein RBM3 for ischemic stroke treatment","volume":"16","author":"\u00c1vila-G\u00f3mez","year":"2025","journal-title":"Front Pharmacol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.757135","article-title":"The RNA-binding motif protein family in cancer: Friend or foe","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14755","article-title":"RNA binding motif protein 3: a potential biomarker in cancer and therapeutic target in neuroprotection","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/2050-7771-2-11","article-title":"High expression of RNA-binding motif protein 3 in esophageal and gastric adenocarcinoma correlates with intestinal metaplasia-associated tumours and independently predicts a reduced risk of recurrence and death","volume":"2","author":"Jonsson","year":"2014","journal-title":"biomark Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/his.12726","article-title":"Loss of <scp>RNA<\/scp> \u2010binding motif protein 3 expression is associated with right\u2010sided localization and poor prognosis in colorectal cancer","volume":"68","author":"Melling","year":"2016","journal-title":"Histopathology"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.905314","article-title":"High RNA-binding motif protein 3 (RBM3) expression is independently associated with prolonged overall survival in intestinal-type gastric cancer","volume":"23","author":"Ye","year":"2017","journal-title":"Med Sci Monit"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1186\/s12885-018-5032-z","article-title":"Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome","volume":"18","author":"Grupp","year":"2018","journal-title":"BMC Cancer"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.21037\/jgo-24-331","article-title":"High expression of RBM15 is associated with better prognosis in esophageal squamous cell carcinoma","volume":"15","author":"Liu","year":"2024","journal-title":"J Gastrointest Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2019.00065","article-title":"Post-transcriptional regulation of colorectal cancer: A focus on RNA-binding proteins","volume":"6","author":"Garc\u00eda-C\u00e1rdenas","year":"2019","journal-title":"Front Mol Biosci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000020002","article-title":"The prognostic and clinicopathological significance of RBM3 in the survival of patients with tumor: A Prisma-compliant meta-analysis","volume":"99","author":"Gao","year":"2020","journal-title":"Medicine"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaa078","article-title":"Cold stress protein RBM3 responds to hypothermia and is associated with good stroke outcome","volume":"2","author":"\u00c1vila-G\u00f3mez","year":"2020","journal-title":"Brain Commun"},{"key":"B23","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.molmed.2018.03.008","article-title":"RNA binding proteins in intestinal epithelial biology and colorectal cancer","volume":"24","author":"Chatterji","year":"2018","journal-title":"Trends Mol Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.06.030","article-title":"The RNA-binding protein RBM3 promotes cell proliferation in hepatocellular carcinoma by regulating circular RNA SCD-circRNA 2 production","volume":"45","author":"Dong","year":"2019","journal-title":"EBioMedicine"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-23-84","article-title":"m6A reading protein RBMX as a biomarker for prognosis and tumor progression in esophageal cancer","volume":"12","author":"Tuersun","year":"2023","journal-title":"Transl Cancer Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.914513","article-title":"RNA-binding motif 4 (RBM4) suppresses tumor growth and metastasis in human gastric cancer","volume":"25","author":"Yong","year":"2019","journal-title":"Med Sci Monit"},{"key":"B27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41392-023-01367-x","article-title":"RBM4 dictates ESCC cell fate switch from cellular senescence to glutamine-addiction survival through inhibiting LKB1-AMPK-axis","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct Tgt Ther"},{"key":"B28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.biochi.2023.04.003","article-title":"Regulation of cold-inducible RNA-binding protein (CIRBP) in response to cellular stresses","volume":"217","author":"Corre","year":"2024","journal-title":"Biochimie"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26115159","article-title":"hnRNPH1: A multifaceted regulator in RNA processing and disease pathogenesis","volume":"26","author":"Zhu","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092699","article-title":"RNA-binding proteins in cancer: Functional and therapeutic perspectives","volume":"12","author":"Kang","year":"2020","journal-title":"Cancers Bsl"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2016.01.012","article-title":"Potent effects of dioscin against gastric cancer in vitro and in vivo","volume":"23","author":"Zhao","year":"2016","journal-title":"Phytomedicine"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2018.11.019","article-title":"Low expression of RBMS3 and SFRP1 are associated with poor prognosis in patients with gastric cancer","volume":"6","author":"Zhang","year":"2016","journal-title":"Am J Cancer Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/MIB.0000000000000987","article-title":"Stress response protein RBM3 promotes the development of colitis-associated cancer","volume":"23","author":"Sakurai","year":"2017","journal-title":"Inflammation Bowel Dis"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1080\/15476286.2024.2413820","article-title":"Rbm3 deficiency leads to transcriptome-wide splicing alterations","volume":"21","author":"Erkelenz","year":"2024","journal-title":"RNA Biol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1790197\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T04:42:40Z","timestamp":1775018560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1790197\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":34,"alternative-id":["10.3389\/fonc.2026.1790197"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1790197","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"article-number":"1790197"}}